Depo-Eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr. 22.5 mg
Active ingredient: Leuprorelin
View notice details →News topic
Active ingredient Leuprorelin
Current shortage notices for the active ingredient Leuprorelin, structured by product, country and reporting period.
3 noticesWhat the Leuprorelin notices indicate for the supply chain
The 3 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
GDP-capable pharmaceutical storage in Cheb
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Depo-Eligard 22.5 mg inj. sol. (pwdr. + solv.) s.c. pre-filled syr. 22.5 mg
Active ingredient: Leuprorelin
View notice details →Depo-Eligard 22.5 mg inj. opl. (pdr. + oplosm.) s.c. voorgev. spuit 22.5 mg
Active ingredient: Leuprorelin
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →